Recombinant Human Proto-oncogene tyrosine-protein kinase Src/SRC Protein was resolved with SDS-PAGE under reducing (Lane 1) and non-reducing (Lane 2) conditions.
The activity of SRC is based on the MSA technology, and the content and ratio of the substrate and the product are directly separated and detected in real time and dynamically by the different migration rates of the substrate and the product after the enzymatic reaction.
Proto-oncogene tyrosine-protein kinase Src, also known as c-Src, is a non-receptor tyrosine kinase protein that in humans is encoded by the SRC gene. It includes an SH2 domain, an SH3 domain and a tyrosine kinase domain. When src is activated, it promotes survival, angiogenesis, proliferation and invasion pathways. It also regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion, and regulates matrix metalloproteinase-9 activity after intracerebral hemorrhage.
